SubscribeLogin
Published

Moderna receives full U.S. approval for COVID-19 vaccine

Summary by Reuters
Moderna Inc said on Monday it had received full approval from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine for individuals 18 years of age and older. The vaccine received an emergency use authorization in December 2020, and Moderna in August last year said it had completed the filing process for full approval of the vaccine. Pfizer and partner BioNTech's COVID
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 59% of the sources are Center
58% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

VaccinationsVaccinations
FDAFDA
North AmericaNorth America
VaccinesVaccines
CoronavirusCoronavirus
MedicalMedical
PandemicPandemic
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal